Skip to content

Neurooncological register study

Neurooncological register study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033855
Enrollment
3000
Registered
2024-03-18
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: A questionnaire consisting of a compilation of scientifically established and standardized questions regarding the functionality, psychosocial, emotional and physical well-being of the patien

Sponsors

Neurologische Klinik, Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All adult patients with a confirmed brain tumor who present at the Neurology Clinic of Heidelberg University Hospital and who are capable of providing information are to be informed and, if they give their consent, included.

Exclusion criteria

Exclusion criteria: Exclusion criteria are patient age under 18 years, lack of capacity to consent and the absence of a confirmed brain tumor. In addition, patients are excluded if they withdraw their consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
Quality of life

Secondary

MeasureTime frame
Seizure frequency

Countries

Germany

Contacts

Public ContactTobias Kessler

Neurologische Klinik, Universitätsklinikum Heidelberg

neurologie@med.uni-heidelberg.de06221 56-6999

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026